New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 22, 2014
10:06 EDTWUBA, YOKU, AMPE, DKS, GME, ARWR, SPLS, FOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD GME YOKU SPLS DKS WUBA ARWR ACHN
News For AMPE;FOLD;GME;YOKU;SPLS;DKS;WUBA;ARWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 20, 2015
09:18 EDTYOKUYouku Tudou downgraded to Sell from Hold at Deutsche Bank
Subscribe for More Information
07:37 EDTGMEGameStop should be bought if pulls back after Q4 report, says RW Baird
Subscribe for More Information
07:25 EDTYOKUYouku Tudou price target lowered to $20 from $24 at Brean Capital
Subscribe for More Information
March 19, 2015
18:58 EDTYOKUOn The Fly: After Hours Movers
UP AFTER EARNINGS: Mattress Firm (MFRM), up 5.2%... New York & Company (NWY), up 3.1%... Rally Software (RALY), up 1.4%... Nike (NKE), up 4.2%... Youku Tudou (YOKU), up 1%. ALSO HIGHER: Prothena (PRTA), up 39.3% after reporting positive results from Phase 1 study of PRX002... SeaWorld (SEAS), up 1% after naming Joel Manby as president and CEO. DOWN AFTER EARNINGS: AK Steel (AKS), down 9.1%.
18:05 EDTYOKUYouku Tudou sees Q1 revenue RMB1.01B-RMB1.03B, consensus RMB996.47M
Subscribe for More Information
18:04 EDTYOKUYouku Tudou reports Q4 adjusted EPS RMB (1.18), consensus RMB (1.00)
Subscribe for More Information
16:26 EDTFOLDOn The Fly: Closing Wrap
Stocks on Wall Street opened lower but turned mixed early in the day and remained that way for most of the session. The Dow and S&P spent most of the day deep in negative territory, while the Nasdaq managed to stay just above the flat line. Investors had a chance to digest yesterday’s comments from the Fed and may have re-considered whether it latest policy stance was as dovish as originally believed. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 1K to 291K in the week ended March 14, which nearly matched the consensus 293K forecast. The current account deficit widened to $113.5B in Q4 from a revised deficit of $98.9B in Q3. The leading indicators for February rose 0.2% to 121.4, which was in-line with expectations. The Philadelphia Fed business outlook survey ticked down to a 5.0 one-year low from 5.2 in February, missing expectations for it to have risen a 7.0 reading. COMPANY NEWS: Apple (AAPL) joined the Dow Jones Industrial Average after the close last night, replacing AT&T (T). Shares of Apple finished their first day in the blue chip index down 97c, or 0.76%, at $127.50, while AT&T fell 39c, or 1.16%, to $33.20... Coffee giant Starbucks (SBUX) rose $1.92, or 2%, to close at $97.76 after hitting a new all-time high of $99.20 earlier. The move follows the company's investor day meeting yesterday, where it unveiled plans for two pilots of delivery services, reported a partnership to expand the distribution of its ready-to-drink products in China, and announced that its board has declared the sixth two-for-one split of the company’s stock since its IPO in 1992. Goldman Sachs and Wells Fargo were both unphased by the record highs and predicted the rally is not over for Starbucks in upbeat notes on the stock today. MAJOR MOVERS: Among the notable gainers was Amicus Therapeutics (FOLD), which rose $3.11, or 33.26%, to $12.46 after reporting positive results in meetings with the EMA and FDA. Also higher was Wynn Resorts (WYNN), which gained $7.19, or 5.85%, to $130.11 after research firm Brean Capital last night initiated coverage of the stock and several casino peers with Buy ratings. Among the noteworthy losers was Transocean (RIG), which fell $1.09, or 7.15%, to $14.16 after saying that it intends to scrap four rigs and noting that with those it has announced plans to scrap a total of 16 floaters. Also lower after its earnings report was diversified apparel company Vince Holding (VNCE), which fell $3.50, or 16.36%, to $17.89. INDEXES: The Dow fell 117.16, or 0.65%, to 17,959.03, the Nasdaq gained 9.55, or 0.19%, to 4,992.38, and the S&P 500 declined 10.23, or 0.49%, to 2,089.27.
15:27 EDTYOKUYouku Tudou March 15 straddle priced for 6.5% movement into Q4
Subscribe for More Information
14:43 EDTYOKUYouku Tudou technical comments ahead of earnings
Shares are trading close to the 52-week low at $14.88 ahead of earnings. That low is not just a 52-week low, but is close to the life low area of the shares at $13.76. Sentiment is negative, with 10.5% of the float short. On a positive surprise this could add significant buy-to-cover demand that could help push shares higher. The first significant test of resistance would come at the 50-day moving average at $16.73. A breakout above that downtrend resistance line proxy could help turn the short-term trend to bullish. Resistance levels above the 50-day as potential upside objectives would be at $17.76 and then at $18.50. It would likely take a move above the $20 area to turn the longer-term trend to bullish. If the news is as or even more negative than current expectations, the life lows would be the first significant support. Below $13.76 there would be not established support, leaving open a drift lower to typical option strike prices at $13, $12.50, and $12.
10:42 EDTFOLDOptions with decreasing implied volatility
Subscribe for More Information
10:23 EDTFOLDHigh option volume stocks
Subscribe for More Information
09:37 EDTFOLDActive equity options trading on open
Subscribe for More Information
09:20 EDTFOLDOn The Fly: Pre-market Movers
Subscribe for More Information
08:43 EDTGMEGameStop March weekly volatility elevated into Q4 and outlook
Subscribe for More Information
08:20 EDTFOLDAmicus to host conference call
Subscribe for More Information
07:59 EDTFOLDAmicus NDA submission removes key overhang, says JPMorgan
Subscribe for More Information
06:07 EDTFOLDAmicus reports positive results in meetings with EMA and FDA
Amicus has met with regulatory authorities in Europe and the U.S. to discuss the approval pathways for the oral small molecule pharmacological chaperone migalastat HCl as a precision medicine monotherapy for Fabry patients who have amenable genetic mutations. The company held a meeting with the assigned European Rapporteurs to discuss the upcoming marketing authorization application for migalastat monotherapy. The Rapporteurs agreed that Amicus may submit its MAA for migalastat monotherapy under the Full Approval pathway in the EU and indicated support for Amicus to request Accelerated Assessment. Amicus is accelerating the timing of the MAA submission for full approval for migalastat monotherapy from the middle of 2015 to Q2. Amicus held a Type C meeting with the FDA and plans to submit an NDA for Accelerated Approval, for which the FDA is open to considering several potential surrogate endpoints evaluated in the clinical studies of migalastat. Amicus plans to schedule a pre-NDA meeting and to submit an NDA under Subpart H in 2H15
March 17, 2015
10:26 EDTFOLDOptions with increasing implied volatility
Subscribe for More Information
09:17 EDTWUBA58.com 2.5M share Block Trade priced at $44.10
The deal range was $43.90-$44.20. Credit Suisse acted as sole book running manager for the offering.
07:26 EDTYOKUYouku Tudou volatility elevated into Q4 and outlook
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use